1. Home
  2. SPCB vs IGC Comparison

SPCB vs IGC Comparison

Compare SPCB & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPCB
  • IGC
  • Stock Information
  • Founded
  • SPCB 1988
  • IGC 2005
  • Country
  • SPCB Israel
  • IGC United States
  • Employees
  • SPCB N/A
  • IGC N/A
  • Industry
  • SPCB Semiconductors
  • IGC Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPCB Technology
  • IGC Health Care
  • Exchange
  • SPCB Nasdaq
  • IGC Nasdaq
  • Market Cap
  • SPCB 31.4M
  • IGC 29.4M
  • IPO Year
  • SPCB N/A
  • IGC N/A
  • Fundamental
  • Price
  • SPCB $10.68
  • IGC $0.31
  • Analyst Decision
  • SPCB Strong Buy
  • IGC Strong Buy
  • Analyst Count
  • SPCB 1
  • IGC 2
  • Target Price
  • SPCB $18.00
  • IGC $3.75
  • AVG Volume (30 Days)
  • SPCB 700.4K
  • IGC 390.0K
  • Earning Date
  • SPCB 11-14-2024
  • IGC 02-25-2025
  • Dividend Yield
  • SPCB N/A
  • IGC N/A
  • EPS Growth
  • SPCB N/A
  • IGC N/A
  • EPS
  • SPCB 1.02
  • IGC N/A
  • Revenue
  • SPCB $26,843,000.00
  • IGC $1,236,000.00
  • Revenue This Year
  • SPCB $6.72
  • IGC N/A
  • Revenue Next Year
  • SPCB $16.91
  • IGC $13.38
  • P/E Ratio
  • SPCB $10.47
  • IGC N/A
  • Revenue Growth
  • SPCB 5.23
  • IGC N/A
  • 52 Week Low
  • SPCB $2.55
  • IGC $0.27
  • 52 Week High
  • SPCB $18.95
  • IGC $0.91
  • Technical
  • Relative Strength Index (RSI)
  • SPCB 52.69
  • IGC 42.69
  • Support Level
  • SPCB $9.32
  • IGC $0.29
  • Resistance Level
  • SPCB $11.30
  • IGC $0.33
  • Average True Range (ATR)
  • SPCB 1.19
  • IGC 0.01
  • MACD
  • SPCB -0.40
  • IGC 0.00
  • Stochastic Oscillator
  • SPCB 37.12
  • IGC 43.20

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.

Share on Social Networks: